The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Testosterone is Associated With Nonalcoholic Steatohepatitis (NASH) and Fibrosis in Pre-Menopausal Women With NAFLD
Monika Sarkar1, Ayako Suzuki2, Manal Abdelmalek2, Katherine Yates3, Laura Wilson3, Nathan M Bass4, Ryan Gill2, Marcelle Cedars5, Norah Terrault6, NASH Clinical Research Network (NASH CRN)
Author information
1University of California, San Francisco (UCSF), Division of Gastroenterology and Hepatology, San Francisco, California. Electronic address: monika.sarkar@ucsf.edu.
2Duke University, Division of Gastroenterology and Hepatology, Durham, North Carolina.
3Johns Hopkins University, Department of Epidemiology and Biostatistics, Baltimore, Maryland.
4University of California, San Francisco (UCSF), Division of Gastroenterology and Hepatology, San Francisco, California.
5UCSF, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, San Francisco, California.
6University of Southern California, Division of Gastroenterology and Hepatology, Los Angeles, California.
Abstract
Background: Higher testosterone contributes to imaging-confirmed nonalcoholic fatty liver disease (NAFLD) in women, but whether testosterone influences their disease severity is unknown.
Methods: The association of free testosterone (free T) with nonalcoholic steatohepatitis (NASH) was determined in pre-menopausal women with biopsy-confirmed NAFLD (n=207). Interaction testing was performed for age and free T given decline in testosterone with age, and association of aging with NASH. Regression models adjusted for abdominal adiposity, diabetes, and dyslipidemia.
Results: Median age was 35 yrs (IQR 29-41); 73% were white, 25% Hispanic; 32% had diabetes, 93% abdominal adiposity, and 95% dyslipidemia. 69% had NASH, 67% any fibrosis, and 15% advanced fibrosis. Higher free T levels were associated with NAFLD severity in younger women (interaction p values <0.02). In the youngest age quartile, free T was independently associated with NASH (OR 2.3, 95% CI 1.2-4.4), NASH fibrosis (2.1, 95% CI 1.1-3.8), and higher fibrosis stage (OR 1.9, 95% CI 1.1-3.4), p values ≤ 0.02. In these women, the proportion with NASH (from 27% to 88%) and NASH fibrosis (from 27% to 81%) steadily rose with higher free T quartiles (p<0.01). Free T was additionally associated with abdominal adiposity among all pre-menopausal women (OR 2.2, 95% CI 1.2-4.1, p=0.015).
Conclusions: In young women with NAFLD, higher testosterone levels conferred a two-fold higher risk of NASH and NASH fibrosis, and increased risk of abdominal adiposity, supporting a potential mechanistic link of abdominal fat on testosterone-associated liver injury. Testosterone may represent an early risk factor for NASH progression in young women, prior to their onset of more dominant, age-related metabolic risk factors.